Health
Preclinical data for the COVID-19 vaccine candidate shows efficacy and benefits – AlKhaleej Today
Preclinical data for the COVID-19 vaccine candidate shows efficacy and benefits
Photo credit: CC0 Public Domain
A COVID-19 vaccine candidate that underwent extensive preclinical testing at the University of Alabama in Birmingham during the spring and summer shows strong preclinical immune responses including several that differentiate it from other COVID-19 vaccine approaches, according to a preprint stored in the BioRxiv repository differ this week.
Partial preclinical results were announced in July and August by Maryland-based Altimmune Inc., a clinical-stage biopharma…
-
Noosa News22 hours agoEnsure voices are heard – Proctor
-
Business19 hours agoUp 34% this year, can Challenger shares keep rising according to Macquarie?
-
Noosa News23 hours agoCity of Moreton Bay claims homeless people consented to having camps thrown away
-
General23 hours agoReserve Bank board still looking for yesterday’s news